copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Waters acquires BDs biosciences unit in $17. 5bn deal BY Fraser Tennant In a transaction that creates an innovative life science and diagnostics leader, US laboratory equipment maker Waters is to acquire medical technology firm Becton Dickinson (BD) for approximately $17 5bn Under the terms of the definitive agreement, BD’s shareholders will own approximately 39 2 percent of the combined company, and existing Waters shareholders are expected
Waters, BD biosciences unit agree to $17. 5B merger Waters, BD biosciences unit agree to $17 5B merger The BD business will be spun off and merged with a Waters subsidiary Waters shares were down 11% in early trading Monday on the news
Waters Corporations $17. 5B Deal with BD: Building a Life Sciences . . . Waters Corporation's $17 5B Deal with BD: Building a Life Sciences Powerhouse Through Synergies and ScaleI analyze economic developments and monetary policy to help readers understand their impact on the financial landscape
Investor Relations - Waters Highly resilient long-term growth profile Embedded in small molecule, biologics and novel modality testing applications
Waters Easily navigate to the right products and solutions for all your chromatographic challenges with Waters product selection tools
Waters Videos See how ions move through our mass spectrometers Learn how to advance your chromatography skills Watch how Waters scientists use our analytical technologies for differing applications Listen to our customers who describe how Waters’ solutions improve their laboratories Our videos are almost as good as a seat in our demo labs